San Diego, California–(Newsfile Corp. – July 3, 2022) – Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Adagio Therapeutics, Inc. (“Adagio ” or the “Company”) (NASDAQ: ADGI), any of its executive officers, or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focus on investors’ losses and whether they may be recovered under the federal securities laws.What if I purchased Adagio common stock?…
